The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis (Q44133715)
Jump to navigation
Jump to search
scientific article published in September 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis |
scientific article published in September 2002 |
Statements
1 reference
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis (English)
1 reference
Charlott Brunmark
1 reference
Anna Runström
1 reference
Lennart Ohlsson
1 reference
Birgitta Sparre
1 reference
Thomas Brodin
1 reference
Mikael Aström
1 reference
Gunnar Hedlund
1 reference
1 September 2002
1 reference
1 reference
130
1 reference
1-2
1 reference
163-172
1 reference
Identifiers
1 reference
1 reference